granzyme B Antibodies

Santa Cruz Biotechnology provides a broad selection of granzyme B monoclonal antibodies for research in understanding the mechanisms of immune response and apoptosis. Granzyme B monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Granzyme B is a serine protease that plays a critical role in the immune system, particularly in the cytotoxic activity of T cells and natural killer cells. The protein is involved in the induction of apoptosis in target cells, making it essential for the elimination of infected or malignant cells. Understanding granzyme B function is vital for developing therapeutic strategies against various diseases, including cancer and viral infections. Researchers worldwide rely on granzyme B monoclonal antibodies to advance their studies in immune regulation and cellular mechanisms. Characterization of granzyme B has revealed its significance in multiple biological pathways and disease states. Current investigations continue to uncover new aspects of granzyme B's role in immune responses and potential therapeutic applications. Santa Cruz Biotechnology monoclonal antibodies for granzyme B support cutting-edge research that advances our understanding of immune system function and disease treatment strategies.